Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1D | P48730 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | KIF11 | P52732 | 2/20 | 0.38 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.38 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.38 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.38 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | CASP3 | P42574 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | SENP8 | Q96LD8 | 2/20 | 0.36 |
| ▸ | SENP7 | Q9BQF6 | 2/20 | 0.36 |
| ▸ | SENP6 | Q9GZR1 | 2/20 | 0.36 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30719048 | 0.85 | CSNK1D (0.47) | CSNK1DESR1LMNAALDH1A1GAA | |
| SCHEMBL23927543 | 0.85 | CSNK1D (0.47) | CSNK1DESR1LMNAALDH1A1GAA | |
| SCHEMBL12320134 | 0.85 | GAA (0.45) | CSNK1DKIF11TP53SLC2A1ALDH1A1 | |
| SCHEMBL12320095 | 0.80 | RAPGEF4 (0.55) | MAPK13MAPK12MAPK11MAPK14LMNA | |
| SCHEMBL19087611 | 0.79 | TAS2R14 (0.50) | TP53SLC2A1LMNAALDH1A1NPC1 | |
| SCHEMBL12320094 | 0.77 | MAPT (0.48) | TP53SLC2A1LMNAALDH1A1NPC1 | |
| SCHEMBL28194326 | 0.74 | AKR1C3 (0.49) | CSNK1DSLC2A1LMNAALDH1A1GAA | |
| SCHEMBL31231923 | 0.74 | MAPT (0.52) | LMNAALDH1A1NPC1RAB9AL3MBTL1 | |
| SCHEMBL16418618 | 0.74 | TSHR (0.41) | ESR1LMNAALDH1A1NPC1CASP3 | |
| SCHEMBL12320096 | 0.73 | MAPT (0.36) | MAPK13MAPK12MAPK11MAPK14TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8017774-B2 | Producing method for iridium complex | CANON KABUSHIKI KAISHA (JP) | 2011-09-13 | — | — | US | disclosed |
| US-20070232803-A1 | PRODUCING METHOD FOR IRIDIUM COMPLEX | CANON KABUSHIKI KAISHA (JP) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232803-A1 | PRODUCING METHOD FOR IRIDIUM COMPLEX | LAGE3, EML4, INTS9 | CSNK1D 4218/4885ESR1 98/4885KIF11 1445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.